Angiography Devices Market Size & Share to 2026 : AngioDynamics, Medtronic, Shimadzu Corporation, Cardinal Health., Boston Scientific Corporation, Canon Inc., Siemens Healthcare GmbH

North America Angiography Devices Market By Product (Angiography Systems, Angiography Contrast Media, Vascular Closure Devices, Angiography Balloons, Angiography Catheters, Angiography Guidewires, Angiography Accessories), Technology (X-Ray Angiography, Ct Angiography, Mr Angiography, Other Angiography Technologies), Procedure (Coronary Angiography, Endovascular Angiography, Neuroangiography, Onco-Angiography, Other Angiography Procedures), Indication (Coronary Artery Disease, Valvular Heart Disease, Congenital Heart Disease, Congestive Heart Failure, Other Indications), Application (Diagnostics, Therapeutics), End User (Hospitals & Clinics, Diagnostic & Imaging Centers, Research Institutes ), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2026

To get a Sample Copy of the Report, along with the TOC, Statistics, and Tables, please visit@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-angiography-devices-market

Key Market Competitors:

Terumo Corporation,
Abbott,
B. Braun Melsungen AG,
AngioDynamics,
Medtronic,
Shimadzu Corporation,
Cardinal Health.,
Boston Scientific Corporation,
Canon Inc.,
Siemens Healthcare GmbH,
Koninklijke Philips N.V.,
GENERAL ELECTRIC COMPANY,
MEDTRON AG,
CANON MEDICAL SYSTEMS CORPORATION,
Merit Medical Systems and others.

Market Analysis: North America Angiography Devices Market

North America angiography devices market is registering a substantial CAGR in the forecast period of 2019-2026. This rise in the market can be attributed to the increment in aging population and CVD incidence and Increasing awareness programs, conferences, and fundraising activities.

Market Definition: North America Angiography Devices Market

Angiography is the X-ray imaging of blood vessels by means of contrast agents inserted into the bloodstream through a small plastic pipe (catheter) that is positioned straight in the blood vessel. The pictures are called angiograms. Angiography offers data on defects in the blood vessels, such as shrinking, obstruction, swelling, unusual enlargement and bleeding, using a liquid contrast agent recognized as a contrast medium. Contrast agents are introduced into the artery or vein to render the blood vessels transparent to the x-rays. Angiography is also used to direct processes for the treatment of defects in blood vessels.

Key Highlights of Report

· Overview of key market forces propelling and restraining market growth

· Offers a clear understanding of the competitive landscape and key product segments

· An analysis of strategies of major competitors

· Detailed analyses of industry trends

· A well-defined technological growth map with an impact-analysis

· Provides profiles of major competitors of the market.

· Details of their operations, product and services.

· Recent developments and key financial metrics.

Segmentation: North America Angiography Devices Market

By Product

Angiography Systems
Angiography Contrast Media
Vascular Closure Devices
Angiography Balloons
Angiography Catheters
Angiography Guidewires
Angiography Accessories

By Technology

X-Ray Angiography
Image Intensifiers
Flat-Panel Detectors
Ct Angiography
Mr Angiography
Other Angiography Technologies

By Procedure

Coronary Angiography
Endovascular Angiography
Neuroangiography
Onco-Angiography
Other Angiography Procedures

By Indication

Coronary Artery Disease
Valvular Heart Disease
Congenital Heart Disease
Congestive Heart Failure
Other Indications

By Application

Diagnostics
Therapeutics

By End User

Hospitals & Clinics
Diagnostic & Imaging Centers
Research Institutes

By Country

U.S.
Canada
Mexico

Key Developments in the Market:

In July 2018, GE Healthcare and Lantheus Holdings, Inc., parent company of Lantheus Medical Imaging, Inc., have begun a second phase 3 clinical trial of flurpiridaz 18F, an investigational drug being assessed for coronary artery disease. Flurpiridaz18F has been developed as a myocardial perfusion imaging (MPI) positron resonance tomography (PET).

In February 2017, Philips introduced the latest Azurion intervention platform for image-guided treatment. The system involves hardware and software changes intended to allow clinicians to conduct complicated intervention processes more effectively. This brand release has extended the company's brand range and boosted its market share.

Competitive Analysis:

North America angiography devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Angiography Devices Market for North America

Reasons to Purchase this Report

Current and future of North America angiography devices market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Market Drivers

increment in aging population and CVD incidence is driving the growth of the market
Increasing awareness programs, conferences, and fundraising activities is propelling the growth of the market
Increasing interest of interventional angiography systems in minimally invasive surgery is boosting the growth of the market
Rising the strain of incidence of chronic cardiovascular disease is contributing to the growth of the market

Market Restraints

Reimbursement limits for angiography procedures is hampering the growth of the market
Exposure to radiation Hazard is hindering the growth of the market
Heavy Procedure and Expense of Equipment is restricting the growth of the market

View Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=north-america-angiography-devices-market

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.